Ironwood Pharmaceuticals (IRWD) Appoints Douglas Williams, Ph.D., To Board Of Directors
6/4/2014 7:08:42 AM
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today the appointment of Douglas Williams, Ph.D., to its board of directors. Dr. Williams currently serves as executive vice president, research and development for Biogen Idec Inc. and was previously chief executive officer of ZymoGenetics, Inc.
Help employers find you! Check out all the jobs and post your resume.
comments powered by